[Cardiac arrest following treatment with non-cardiologic QT-interval-increasing medications].
Al-Amood
Safar
S
H:S Rigshospitalet, Kardiologisk Afdeling B. safaa@alamood.dk
Elming
Hanne
H
D001539:Bendroflumethiazide / Q000009:adverse effects; D002090:Butyrophenones / Q000009:adverse effects; D020117:Cisapride / Q000009:adverse effects; D004232:Diuretics / Q000009:adverse effects*; D004562:Electrocardiography; D005260:Female; D005665:Furosemide / Q000009:adverse effects; D005765:Gastrointestinal Agents / Q000009:adverse effects; D006323:Heart Arrest / Q000139:chemically induced*; D006634:Histamine H1 Antagonists / Q000009:adverse effects*; D006801:Humans; D008875:Middle Aged; D010880:Piperidines / Q000009:adverse effects; D011189:Potassium Chloride / Q000009:adverse effects; D049993:Sodium Chloride Symporter Inhibitors / Q000009:adverse effects*; D016171:Torsades de Pointes / Q000139:chemically induced*
D002090:Butyrophenones; D004232:Diuretics; D005765:Gastrointestinal Agents; D006634:Histamine H1 Antagonists; D010880:Piperidines; D049993:Sodium Chloride Symporter Inhibitors; D001539:Bendroflumethiazide; D011189:Potassium Chloride; D005665:Furosemide; C058249:ebastine; D020117:Cisapride